Sort   by:  
 Page size 
TranscriptomicsWhole genome \"TraDIS-Xpress\" assay to determine gene roles during growth of E. coli in different concentrations of the antibiotics trimethoprim and sulfamethoxazole
To assay every gene in the E. coli genome to identify those that contribute to increased or decreased susceptibility to the antibiotics trimethoprim and sulfamethoxazole. This will help to define more accurately those bacterial cell mechanisms that contribute to these phenomena and provide informat...
ORGANISM(S): Escherichia coli str. K-12 substr. MG1655 
2020-10-19 | E-MTAB-9305 | biostudies-arrayexpress
UnknownImpact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.
Not available
S-EPMC8598376 | biostudies-literature
ProteomicsR_OM_Metapyo_32_CF_patients_HILIC_neg
idem R_OM_Metapyo_32_CF_patients_C18_pos we analyzed the metabolome content by untargeted HPLC/HRMS (see supplementary information). Isolates were first grown in synthetic CF medium 2 (SCFM2), a culture medium designed to mimick the nutritional conditions in CF pulmonary mucus (Turner et al. 2014). ...
ORGANISM(S): Pseudomonas Aeruginosa 
2020-01-10 | MSV000084791 | MassIVE
ProteomicsR_OM_Metapyo_32_CF_patients_C18_pos
we analyzed the metabolome content by untargeted HPLC/HRMS (see supplementary information). Isolates were first grown in synthetic CF medium 2 (SCFM2), a culture medium designed to mimick the nutritional conditions in CF pulmonary mucus (Turner et al. 2014). Intracellular metabolic extracts of mid-l...
ORGANISM(S): Pseudomonas Aeruginosa (ncbitaxon:287) 
2020-01-10 | MSV000084790 | MassIVE
MetabolomicsGNPS - R_OM_Metapyo_32_CF_patients_HILIC_neg
idem R_OM_Metapyo_32_CF_patients_C18_pos we analyzed the metabolome content by untargeted HPLC/HRMS (see supplementary information). Isolates were first grown in synthetic CF medium 2 (SCFM2), a culture medium designed to mimick the nutritional conditions in CF pulmonary mucus (Turner et al. 2014). ...
ORGANISM(S): Pseudomonas Aeruginosa 
2020-01-10 | MSV000084791 | GNPS
MetabolomicsGNPS - R_OM_Metapyo_32_CF_patients_C18_pos
we analyzed the metabolome content by untargeted HPLC/HRMS (see supplementary information). Isolates were first grown in synthetic CF medium 2 (SCFM2), a culture medium designed to mimick the nutritional conditions in CF pulmonary mucus (Turner et al. 2014). Intracellular metabolic extracts of mid-l...
ORGANISM(S): Pseudomonas Aeruginosa (ncbitaxon:287) 
2020-01-10 | MSV000084790 | GNPS
UnknownPonatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study.
Not available
S-EPMC3866040 | biostudies-literature
TranscriptomicsHuR- dependent regulation of mRNA splicing is essential for the B cell antibody response [RNA-Seq]
Post-transcriptional regulation of mRNA by the RNA binding protein HuR is required in B cells for the germinal centre reaction and for the production of class-switched antibodies in response to T-independent antigens. Transcriptome-wide examination of RNA isoforms, abundance and translation in HuR-d...
ORGANISM(S): Mus musculus 
2015-02-13 | E-GEOD-62129 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human cancer cell lines
We describe a novel approach combining RNAi screening in multiple cell lines with expression profiling to identify novel cancer targets in breast cancer cell lines
ORGANISM(S): Homo sapiens 
2010-03-02 | E-TABM-610 | biostudies-arrayexpress
TranscriptomicsPemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma
We devised a high-throughput, cell-based assay to identify novel therapeutic compounds to treat Group3 medulloblastoma (G3 MB). Mouse G3 MBs, grown as neurospheres, were screened against a library of approximately 7,000 compounds including FDA-approved drugs. We identified two FDA-approved drugs, ...
ORGANISM(S): Mus musculus 
2014-04-15 | E-GEOD-46406 | biostudies-arrayexpress
Sort   by:  
 Page size